Top Markets
Coin of the day
BioPorto A/S BioPorto A/S

BioPorto A/S

BIOPOR
Rangering i aksjer #21789
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Aksjekurs
$0.20243542
Sist synkronisert: 2026-08-21
Markedsverdi
$100.22M
Endring (1 dag)
2.00%
Endring (1 år)
-0.82%
Land
DK
Handel BioPorto A/S (BIOPOR)

Kategori

P/B-forhold for BioPorto A/S (BIOPOR)
P/B-forhold per 2026 TTM: 0
Ifølge BioPorto A/S sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for BioPorto A/S fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
5.9029 -
US